All News #Library
Biotech
Solu Therapeutics Presents STX-0712 for CMML, AML at ASH
02 Dec 2025 //
PR NEWSWIRE
Solu Therapeutics to Present Data on STX-0712 for Leukemia at ASH
02 Dec 2024 //
PR NEWSWIRE
Solu Appoints Sergio Santillana As Chief Medical Officer
10 Sep 2024 //
PR NEWSWIRE

Market Place
Sourcing Support